Guillain-Barré Syndrome after H1N1 Vaccination in the United States: A Report Using the CDC/FDA Vaccine Adverse Event Reporting System (2009) | Zendy

Nizar Souayah | Zendy; Hussam A. Yacoub | Zendy; Hafiz Khan | Zendy; P.A. Michas-Martin | Zendy; Daniel L. Menkes | Zendy; Leila Maybodi | Zendy; Adnan I. Qureshi | Zendy

Open Access

Guillain-Barré Syndrome after H1N1 Vaccination in the United States: A Report Using the CDC/FDA Vaccine Adverse Event Reporting System (2009)

Author(s) -

Nizar Souayah,

Hussam A. Yacoub,

Hafiz Khan,

P.A. Michas-Martin,

Daniel L. Menkes,

Leila Maybodi,

Adnan I. Qureshi

Publication year - 2012

Publication title -

neuroepidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.217

H-Index - 87

eISSN - 1423-0208

pISSN - 0251-5350

DOI - 10.1159/000336113

Subject(s) - medicine , vaccination , adverse event reporting system , guillain barre syndrome , adverse effect , pediatrics , influenza vaccine , population , immunology , environmental health

Although the Guillain-Barré syndrome (GBS) can be associated with the seasonal influenza vaccine, there is no definite evidence that GBS is associated with H1N1 influenza vaccination. The objective of this report is to study the occurrence and characteristics of GBS after H1N1 vaccine administration in the United States in 2009.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research